Quality of life and illness costs in irritable bowel syndrome.
Quality of life is reduced in patients with irritable bowel syndrome, and the costs for this disease are substantial to society. During a meeting in London, UK, the IBiS club reviewed the literature on these subjects. Drawbacks and advantages with existing instruments to assess quality of life and costs were discussed and the clinical and scientific relevance of the current knowledge was assessed. A summary from the meeting is presented in this paper.
Simrén
Magnus
M
Department of Internal Medicine, Sahlgrenska University Hospital, SE-41345 Goteborg, Sweden. magnus.simren@medicine.gu.se
Brazier
John
J
Coremans
Georges
G
Dapoigny
Michel
M
Müller-Lissner
Stefan A
SA
Pace
Fabio
F
Smout
André J P M
AJ
Stockbrügger
Reinhold W
RW
Vatn
Morten H
MH
Whorwell
Peter J
PJ
D002986:Clinical Trials as Topic; D023381:Endpoint Determination; D017048:Health Care Costs / Q000706:statistics & numerical data*; D006801:Humans; D043183:Irritable Bowel Syndrome / Q000150:complications* / Q000191:economics* / Q000628:therapy; D011788:Quality of Life; D011795:Surveys and Questionnaires